Companies:
10,436
total market cap:
ยฃ82.321 T
Sign In
๐บ๐ธ
EN
English
๐ฉ๐ช Deutsch
๐ซ๐ท Franรงais
ยฃ GBP
$
USD
๐บ๐ธ
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
Watchlist
Account
BeiGene
ONC
#699
Rank
ยฃ21.13 B
Marketcap
๐จ๐ณ
China
Country
ยฃ186.28
Share price
-3.18%
Change (1 day)
61.05%
Change (1 year)
๐ Pharmaceuticals
๐งฌ Biotech
Categories
BeiGene
is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
EPS
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports
ESG Reports
Sustainability Reports
EPS for BeiGene (ONC)
EPS in 2024 (TTM):
-ยฃ4.89
According to
BeiGene
's latest financial reports the company's current EPS (TTM) is
-ยฃ4.69
. .
EPS history for BeiGene from 2015 to 2024
Annual EPS
Year
EPS
Change
2024
-ยฃ4.69
2022
-ยฃ14.65
28.21%
2021
-ยฃ11.42
-19.96%
2020
-ยฃ14.27
20.81%
2019
-ยฃ11.81
31.52%
2018
-ยฃ8.98
417.57%
2017
-ยฃ1.74
-37.16%
2016
-ยฃ2.76
158.95%
2015
-ยฃ1.07
EPS for similar companies or competitors
Company
EPS
EPS
difference
diff.
Country
Onconova Therapeutics
ONTX
-ยฃ0.75
-83.97%
๐บ๐ธ
USA
OPKO Health
OPK
-ยฃ0.20
-95.67%
๐บ๐ธ
USA